GENOMAB Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

GENOMAB General Information

Description

Developer of humanized mouse models designed for preclinical research and drug discovery. The company's platform provides personalized humanized mice, custom model development, and mouse model licensing services, enabling academic institutions, contract research organizations, and pharmaceutical companies to conduct translational research and therapeutic development studies.

Contact Information

Website
www.genomab.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Care Of Harlem Biospace
  • 423 West 127th Street
  • New York, NY 10027
  • United States
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • Care Of Harlem Biospace
  • 423 West 127th Street
  • New York, NY 10027
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GENOMAB Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view GENOMAB’s complete valuation and funding history, request access »

GENOMAB Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Harlem Biospace Accelerator/Incubator
To view GENOMAB’s complete investors history, request access »

GENOMAB FAQs

  • When was GENOMAB founded?

    GENOMAB was founded in 2019.

  • Where is GENOMAB headquartered?

    GENOMAB is headquartered in New York, NY.

  • What industry is GENOMAB in?

    GENOMAB’s primary industry is Biotechnology.

  • Is GENOMAB a private or public company?

    GENOMAB is a Private company.

  • What is GENOMAB’s current revenue?

    The current revenue for GENOMAB is .

  • Who are GENOMAB’s investors?

    Harlem Biospace has invested in GENOMAB.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process